ad image

Platform Technology

1 / 2
Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform
Exposomics

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Manish Arora, Ph.D.

LinusBio

PAO-09-24-CL-06Sep 05, 2024
Facilitating Organoid Production for Biopharmaceutical Applications
Cell Therapy

Facilitating Organoid Production for Biopharmaceutical Applications

Karen Weisinger, Ph.D.

Cell X Technologies

PAO-06-24-CL-12Jul 02, 2024
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

PAO-03-24-CL-08Mar 18, 2024
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Digital Pathology

Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform

Nathan Buchbinder

Proscia

PAO-01-24-CL-2Feb 29, 2024
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

PAO-10-23-CL-03Nov 01, 2023
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Cell Therapy

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Sarah Meeks, Ph.D.

MaxCyte

PAO-09-23-CL-09Sep 28, 2023
Wheeler Bio
Business Leadership

Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer

Wheeler Bio

PR-M08-23-01Aug 15, 2023
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
CDMO Partnerships

Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market

Daniel Buckley

Samsung Biologics

PAO-05-23-CL-07Jun 19, 2023
Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Martin Akerman, Ph.D.

Envisagenics

PAO-02-23-CL-08Apr 12, 2023
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

Denis Dufrane, M.D., Ph.D.

PAO-03-23-CL-06Mar 20, 2023
Charles River Laboratories
Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Charles River Laboratories

PR-M03-23-03Mar 14, 2023
Terumo Blood and Cell Technologies
T Cell Expansion Platform

Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose

Terumo Blood and Cell Technologies

PR-M02-23-03Feb 23, 2023
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
CAR-T

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

Ryan Larson, Ph.D.

PAO-12-022-CL-04Jan 03, 2023
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

PAO-12-022-NI-01Dec 23, 2022
Umoja Biopharma
CAR-T and iPSC Platform Technologies

Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting

Umoja Biopharma

PR-M11-22-06Nov 11, 2022
Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers
mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight

PAO-10-022-CL-03Oct 25, 2022
Wheeler Bio
Series A Funding

Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma

Wheeler Bio

PR-M10-22-02Oct 05, 2022
Generis
Data Management System

Generis Celebrates New Milestones as Swathes of the Global Pharma Industry Default to CARA Life Sciences™ to Manage Critical Data and Content

Generis

PR-M06-22-06Jun 21, 2022
Advanced Instruments
Cell Line Development

Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow

Advanced Instruments

PR-M06-22-04Jun 14, 2022
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Immuno-Oncology

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Derek Hennecke

Inceptor Bio

PAO-05-22-R250-09May 24, 2022
1 / 2